HIGH Altitude CArdiovascular REsearch in the ANDES
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01830530
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01830530
-
- Other papers using this trial's data
- Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study
- Upward Shift and Steepening of the Blood Pressure Response to Exercise in Hypertensive Subjects at High Altitude
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Peru
- Registry status
- Completed
Technical summary
Registry record NCT01830530. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HIGH Altitude CArdiovascular REsearch in the ANDES
- Acronym
- HIGHCARE-A
- Condition
- Hypertension
- Condition
- High Altitude
- Intervention (Drug)
- Telmisartan
- Intervention (Drug)
- Nifedipine
- Intervention (Drug)
- placebo
- Lead sponsor
- Istituto Auxologico Italiano
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct01830530- Content hash
5257b892297ff0c444971139e136eea421032a277055daf9f679fe779eebab4c